Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize HAE Drug in Latin America

News   Feb 04, 2013

 
Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize HAE Drug in Latin America
 
 
 

RELATED ARTICLES

Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication

News

Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV).

READ MORE

Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes Synthesis

News

TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.

READ MORE

Innate Immune Cells Reprogrammed to Fight Tuberculosis

News

A cure has eluded scientists for more than a century but, now, a Montreal team of researchers may have discovered a new weapon to combat this global killer. The team is re-programing - or 'training' - immune cells to kill TB. These groundbreaking findings are published online today in the journal Cell.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE